Vmn2r106 Inhibitors
Vmn2r106 inhibitors consist of a variety of chemical compounds that directly or indirectly suppress the functional activities of this chemosensory receptor through diverse biochemical pathways. For instance, Amiloride, a diuretic known to inhibit sodium channels, leads to a reduction in blood volume and pressure, which could consequently modulate the signaling of Vmn2r106 given its potential role in blood pressure regulation. Similarly, Capsazepine, by antagonizing the transient receptor potential vanilloid 1 (TRPV1), impacts sensory perception pathways that Vmn2r106 may influence. In the realm of neurotransmission, α-Bungarotoxin, which targets nicotinic acetylcholine receptors, and Hexamethonium, which blocks autonomic ganglia, could disrupt cholinergic pathways that modulate Vmn2r106's activity. Additionally, Tetrodotoxin's blockade of voltage-gated sodium channels may attenuate neuronal signaling, thus indirectly influencing Vmn2r106's function.
Moreover, Ondansetron and Diphenhydramine, which antagonize 5-HT3 and histamine H1 receptors, respectively, could alter chemosensory pathways potentially involving Vmn2r106. Ruthenium Red's inhibition of calcium channels, Quinine's blockade of potassium channels, and Methyllycaconitine's antagonism of α7-nicotinic acetylcholine receptors all serve to modulate neuronal excitability and neurotransmitter release, each possibly affecting Vmn2r106 signaling. Bicuculline, through GABA-A receptor inhibition, increases neuronal activity, which may also impact Vmn2r106's chemosensory function. Lastly, Iodoacetic Acid disrupts energy metabolism by targeting GAPDH, which could affect the energy-dependent signaling processes where Vmn2r106 is implicated, demonstrating the extensive network of pathways that can influence the receptor's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is a diuretic that acts as a reversible inhibitor of sodium channels. By blocking these channels, amiloride reduces the reabsorption of sodium in the kidney, leading to decreased blood volume and blood pressure. Reduction in blood pressure can indirectly affect the activity of Vmn2r106, as this protein is a chemosensory receptor potentially involved in blood pressure regulation. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
Capsazepine is a synthetic analog of the sensory irritant capsaicin. It is a selective antagonist of the transient receptor potential vanilloid 1 (TRPV1). By antagonizing TRPV1, capsazepine may affect sensory perception pathways that could be downstream or modulated by the activity of Vmn2r106, thus potentially altering its signaling capacity. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
α-Bungarotoxin is a competitive antagonist for nicotinic acetylcholine receptors. It can indirectly affect the signaling pathways involving cholinergic neurotransmission. Since Vmn2r106 is a chemosensory receptor, changes in acetylcholine signaling could influence the sensory perception mechanisms in which Vmn2r106 may play a role. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Ondansetron is a serotonin 5-HT3 receptor antagonist, commonly used to prevent nausea and vomiting. Inhibition of 5-HT3 receptors could indirectly affect the modulation of sensory pathways and neurotransmission where Vmn2r106 might be implicated, potentially altering its chemosensory signaling function. | ||||||
Hexamethonium bromide | 55-97-0 | sc-205712 sc-205712A | 10 g 25 g | $46.00 $64.00 | ||
Hexamethonium acts as a nicotinic acetylcholine receptor antagonist at the neuromuscular junction and autonomic ganglia. By blocking these receptors, hexamethonium disrupts autonomic transmission, which could affect physiological processes that may be sensed or modulated by Vmn2r106. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is an inhibitor of several ion channels, including calcium channels. By inhibiting calcium channels, it can affect intracellular signaling cascades that may be involved in chemosensor function or regulation, potentially impacting the activity of Vmn2r106 indirectly. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
Quinine is an alkaloid that acts as a blocker of voltage-gated potassium channels. By altering the function of these channels, quinine can modulate neuronal excitability and neurotransmitter release, which may indirectly influence the chemosensory signaling involving Vmn2r106. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Bicuculline is a competitive antagonist for GABA-A receptors, which when inhibited, can lead to increased neuronal firing. This increased activity can indirectly influence sensory pathways including those associated with chemosensation, potentially affecting the function of Vmn2r106. | ||||||
Iodoacetic acid | 64-69-7 | sc-215183 sc-215183A | 10 g 25 g | $57.00 $99.00 | ||
Iodoacetic Acid irreversibly inhibits glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an enzyme in the glycolytic pathway. By disrupting cellular energy metabolism, it could affect the energy-dependent processes involved in signal transduction | ||||||